<SEC-DOCUMENT>0001193125-24-247660.txt : 20241030
<SEC-HEADER>0001193125-24-247660.hdr.sgml : 20241030
<ACCEPTANCE-DATETIME>20241030171330
ACCESSION NUMBER:		0001193125-24-247660
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241030
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241030
DATE AS OF CHANGE:		20241030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wave Life Sciences Ltd.
		CENTRAL INDEX KEY:			0001631574
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			U0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37627
		FILM NUMBER:		241411431

	BUSINESS ADDRESS:	
		STREET 1:		7 STRAITS VIEW
		STREET 2:		#12-00, MARINA ONE EAST TOWER
		CITY:			SINGAPORE
		STATE:			U0
		ZIP:			018936
		BUSINESS PHONE:		617-949-2900

	MAIL ADDRESS:	
		STREET 1:		733 CONCORD AVENUE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WAVE Life Sciences Ltd.
		DATE OF NAME CHANGE:	20170516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wave Life Sciences Ltd.
		DATE OF NAME CHANGE:	20151106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wave Life Sciences LTD.
		DATE OF NAME CHANGE:	20151106
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d862759d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wve="http://www.wavelifesciences.com/20241030" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-237">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-10-30_to_2024-10-30">0001631574</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="wve-20241030.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-10-30_to_2024-10-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001631574</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-10-30</xbrli:startDate> <xbrli:endDate>2024-10-30</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-248">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt:datemonthdayyearen" id="ixv-249">October 30, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-250">WAVE LIFE SCIENCES LTD.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:edgarprovcountryen" id="ixv-251">Singapore</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-252">001-37627</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-253">98-1356880</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-254">7 Straits View #12-00</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-255">Marina One</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-256">East Tower</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:countrynameen" id="ixv-257">Singapore</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-258">018936</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-259">65</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-260">6236 3388</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration:underline">see</span> General Instruction A.2. below):</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:boolballotbox" id="ixv-261">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:boolballotbox" id="ixv-262">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:boolballotbox" id="ixv-263">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:boolballotbox" id="ixv-264">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:boolballotbox" id="ixv-265">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-266">$0 Par Value Ordinary Shares</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-267">WVE</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-10-30_to_2024-10-30" format="ixt-sec:exchnameen" id="ixv-268">The Nasdaq Global Market</ix:nonNumeric></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;7.01 Regulation FD Disclosure. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;30, 2024, Wave Life Sciences Ltd. (the &#8220;Company&#8221;) hosted a virtual analyst and investor Research Day webcast and shared a slide presentation that is available on the &#8220;For Investors&#160;&amp; Media&#8221; section of the Company&#8217;s website at http://ir.wavelifesciences.com/. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, on October&#160;30, 2024, the Company issued a press release summarizing the key information presented during the Company&#8217;s virtual analyst and investor Research Day webcast. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The information in this Item 7.01 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing</span>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;8.01 Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in the press release referred to in Item 7.01 above, other than the second paragraph thereof, is incorporated by reference into this Item 8.01 of this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01 Financial Statements and Exhibits. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d862759dex991.htm">Press Release issued by Wave Life Sciences Ltd. dated October&#160;30, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">WAVE LIFE SCIENCES LTD.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Paul B. Bolno, M.D.</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Paul B. Bolno, M.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President and Chief Executive Officer</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: October 30, 2024 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d862759dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g862759g1031020524732.jpg" ALT="LOGO" STYLE="width:1.83889in;height:1.16667in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA
Editing Programs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">WVE-007</FONT> (INHBE GalNAc-siRNA for obesity) is on track to initiate a clinical trial in 1Q
2025; new preclinical data for <FONT STYLE="white-space:nowrap">WVE-007</FONT> demonstrate opportunities for monotherapy, for synergistic use with <FONT STYLE="white-space:nowrap">GLP-1s,</FONT> and for maintenance to avoid rebound weight gain
following cessation of <FONT STYLE="white-space:nowrap">GLP-1s</FONT> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Recent
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-mechanism</FONT></FONT> data for <FONT STYLE="white-space:nowrap">WVE-006</FONT> unlocked Wave&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> RNA editing capabilities; three new wholly owned RNA editing programs targeting PNPLA3, LDLR and APOB are <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-class</FONT></FONT> approaches to address significant unmet needs in cardiometabolic diseases </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Wave plans to
have five GalNAc-RNA editing or GalNAc-siRNA programs in the clinic by 2026 </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Wave&#146;s clinically validated platform continues to lead on the
improvement of intracellular delivery using novel chemistry, including PN backbone chemistry modifications </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAMBRIDGE,
Mass.,</B><B></B><B>&nbsp;October 30, 2024</B>&nbsp;&#150;&nbsp;Wave Life Sciences Ltd.&nbsp;(Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced
updates across its growing pipeline, which were also discussed during the company&#146;s virtual analyst and investor Research Day (<U>link to webcast</U>). Updates included new preclinical data for Wave&#146;s GalNAc-small interfering RNA (siRNA)
approach for obesity, <FONT STYLE="white-space:nowrap">WVE-007,</FONT> which is on track to initiate a clinical trial in the first quarter of 2025. Wave also introduced new, wholly owned GalNAc-RNA editing programs and demonstrated its leadership in
oligonucleotide chemistry innovation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This year, we showed through multiple positive clinical datasets that our leading RNA medicines platform is
opening up new possibilities for the treatment of human disease. Next to the clinic will be our <FONT STYLE="white-space:nowrap">WVE-007</FONT> program, which reimagines obesity treatment with a mechanism that directly impacts fat cells &#150;
particularly visceral fat &#150; and which could be used as monotherapy, <FONT STYLE="white-space:nowrap">add-on</FONT> to <FONT STYLE="white-space:nowrap">GLP-1s,</FONT> or for maintenance <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">post-GLP-1</FONT></FONT> cessation,&#148; said Paul Bolno, MD, MBA, President and Chief Executive Officer at&nbsp;Wave Life Sciences. &#147;Additionally, we are excited to introduce three new programs for mRNA correction
and upregulation to treat cardiometabolic diseases with significant unmet needs. These programs have substantial, well-defined patient populations, strong support from human genetics, efficient paths to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> in the clinic, and offer the opportunity to meaningfully change health outcomes for millions of people. This truly is an exciting time for Wave and for patients as we unlock new biology and
build our high-value and innovative pipeline.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Key Highlights from Today&#146;s Virtual Research Day </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">WVE-007:</FONT> INHBE GalNAc-siRNA and potential
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> obesity therapeutic approaching the clinic </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">WVE-007</FONT> is Wave&#146;s GalNAc-siRNA that targets INHBE as a novel
approach to treat obesity. The approach is based on human genetics, where individuals who have a protective <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">loss-of-function</FONT></FONT> mutation in the INHBE gene have a healthier
cardiometabolic profile, including less unhealthy visceral fat, lower triglycerides, and lower risk of type 2 diabetes and cardiovascular disease. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g862759g1031020524732.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Silencing of INHBE <I>in vivo</I> directly impacts adipocytes (fat cells) and induces lipolysis (fat burning),
which is different from <FONT STYLE="white-space:nowrap">GLP-1s&#146;</FONT> centrally acting mechanism that involves the digestive system and central nervous system to decrease appetite. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New preclinical data in diet induced obese (DIO) mice demonstrate the potential of
<FONT STYLE="white-space:nowrap">WVE-007</FONT> to be used across the treatment continuum, including as monotherapy, as an <FONT STYLE="white-space:nowrap">add-on</FONT> to <FONT STYLE="white-space:nowrap">GLP-1s,</FONT> and for maintenance to
prevent weight regain and weight cycling after discontinuing <FONT STYLE="white-space:nowrap">GLP-1s.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Wave is on track to initiate a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">WVE-007</FONT> in
adults living with overweight or obesity in the first quarter of 2025. The trial is planned to assess safety, tolerability, pharmacokinetics, and Activin E lowering (a biomarker for target engagement), as well as body composition.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>New GalNAc-RNA editing programs designed to optimally address high-impact cardiometabolic diseases </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Building on Wave&#146;s recent achievement of the first-ever therapeutic RNA editing with <FONT
STYLE="white-space:nowrap">WVE-006</FONT> in <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency, the company today announced three new, wholly owned RNA editing programs that are on track for candidate selection in 2025. Like <FONT
STYLE="white-space:nowrap">WVE-006,</FONT> these programs leverage GalNAc conjugation and have efficient clinical paths to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept.</FONT></FONT> These new programs include:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>PNPLA3 (mRNA correction): </B>Homozygous PNPLA3-I148M patients are at high risk for a variety of liver
diseases and there are more than 9&nbsp;million impacted individuals in the US and Europe. Wave&#146;s RNA editing approach aims to achieve at least 50% correction to restore the heterozygous phenotype with low risk of liver disease, similar to the
approach with <FONT STYLE="white-space:nowrap">WVE-006.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>LDLR (mRNA upregulation) and APOB (mRNA correction): </B>High unmet needs remain among familial
hypercholesterolemia (FH) patients, with approximately half of patients not reaching goal <FONT STYLE="white-space:nowrap">LDL-c</FONT> levels with available therapies. Wave&#146;s AIMers to upregulate LDLR and correct APOB have potential to be <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> treatment approaches for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> effects to reach target <FONT
STYLE="white-space:nowrap">LDL-c</FONT> levels in Heterozygous FH (HeFH) patients. Combined, LDLR and APOB AIMers would address ~1&nbsp;million HeFH patients in the US and Europe. LDLR upregulation also offers significant expansion opportunities in
patients with statin intolerance or prior cardiovascular events (~30&nbsp;million patients in the US and Europe). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Chemistry
innovation enhancing intracellular delivery </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Today, Wave shared data demonstrating how its proprietary chemistry results in marked improvements in five key
areas of intracellular delivery: 1) cellular uptake; 2) endosomal release; 3) cellular residency; 4) nuclear uptake; and 5) target engagement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Wave shared how it is using PN variants and modifications to physicochemical properties to achieve <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> siRNA silencing and RNA editing in a variety of extrahepatic tissues. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Wave also highlighted novel chemistry used in its AIMers, including proprietary <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">N-3-uridine</FONT></FONT> chemistry (N3U), which substantially enhances RNA editing efficiency. This novel chemistry was the subject of a recent <I><U>Nucleic Acids Research</U></I><I> </I>publication.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An archived webcast of the event can be accessed by visiting &#147;Investor Events&#148; on the investor relations section of
the&nbsp;Wave Life Sciences&nbsp;website:&nbsp;<U>https://ir.wavelifesciences.com/events-publications/events</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About</B><B></B><B>&nbsp;Wave Life
Sciences </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human
health. Wave&#146;s RNA medicines platform, PRISM<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both
rare and prevalent disorders. Its toolkit of <FONT STYLE="white-space:nowrap">RNA-targeting</FONT> modalities includes editing, splicing, RNA </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g862759g1031020524732.jpg" ALT="LOGO" STYLE="width:1.83819in;height:1.16667in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave&#146;s
diversified pipeline includes clinical programs in Duchenne muscular dystrophy, <FONT STYLE="white-space:nowrap">Alpha-1</FONT> antitrypsin deficiency and Huntington&#146;s disease, as well as a preclinical program in obesity. Driven by the calling
to &#147;Reimagine Possible&#148;, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave&#146;s science, pipeline and
people, please visit <U>www.wavelifesciences.com</U> and follow Wave on <U>X</U> (formerly Twitter) and <U>LinkedIn</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements concerning our goals, beliefs, expectations, strategies, objectives and plans, and other
statements that are not necessarily based on historical facts, including statements regarding the following, among others: the anticipated initiation, site activation, patient recruitment, patient enrollment, dosing, generation and reporting of data
and completion of our clinical trials, including interactions with regulators and any potential registration based on these data, and the timing and announcement of such events; regulatory submissions and timing for regulatory feedback; the
protocol, design and endpoints of our clinical trials; the future performance and results of our programs in clinical trials; our expectations with respect to how our clinical data successes to date may predict success for our future therapeutic
candidates, future clinical data readouts and further validate of our platform; ongoing and future preclinical activities and programs; the potential of our preclinical data to predict the behavior of our compounds in humans; our identification and
expected timing of future product candidates and their therapeutic potential; the anticipated benefits of our therapeutic candidates and pipeline compared to our competitors; patient population estimates related to our therapeutic candidates and the
potential addressable market that our therapeutics may address; our ability to design compounds using various modalities and the anticipated benefits of that approach; the breadth and versatility of our PRISM drug discovery and development platform;
the expected benefits of our stereopure oligonucleotides compared with stereorandom oligonucleotides; the potential benefits of our RNA editing capability, including our AIMers, compared to others; the benefits of RNA medicines generally; the
potential for certain of our programs to be <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class;</FONT></FONT> the
potential benefits that our &#147;edit-verse&#148; may provide us, including identifying new RNA editing targets; our ability to translate genetic insights into high impact medicines; the status and progress of our programs relative to potential
competitors; the progress and potential benefits of our collaborations; ;and the anticipated duration of our cash runway and our ability to fund future operations. The words &#147;may,&#148; &#147;will,&#148; &#147;could,&#148; &#147;would,&#148;
&#147;should,&#148; &#147;expect,&#148; &#147;plan,&#148; &#147;anticipate,&#148; &#147;intend,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;potential,&#148; &#147;continue,&#148;
&#147;target&#148; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on
management&#146;s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual results to differ materially from those indicated by these forward-looking statements as a result of
these risks, uncertainties and important factors, including, without limitation, the risks and uncertainties described in the section entitled &#147;Risk Factors&#148; in Wave&#146;s most recent Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> filed with the Securities and Exchange Commission (SEC), as amended, and in other filings Wave makes with the SEC from time to time. Wave undertakes no obligation to update the information contained in
this press release to reflect subsequently occurring events or circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact: </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kate Rausch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">617-949-4827</FONT></FONT> <U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>krausch@wavelifesci.com</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alicia Suter </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">617-949-4817</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>asuter@wavelifesci.com</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>wve-20241030.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 10/31/2024 1:03:27 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:wve="http://www.wavelifesciences.com/20241030"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.wavelifesciences.com/20241030"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wve-20241030_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wve-20241030_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>wve-20241030_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 10/31/2024 1:03:27 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>wve-20241030_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 10/31/2024 1:03:27 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wve-20241030.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g862759g1031020524732.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g862759g1031020524732.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !N *X# 2(  A$! Q$!_\0
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M*\DU[X[:?I.M76GVNC37B6TAB:8SB,,RG!P-IXSWK-_X:'@_Z%J3_P #1_\
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M K+0;,[/."6Z#OY48&3_ .@C\37F_P /]-_MWQA8VS*&AC;SI@1D;%YP?8G
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M3K1TVW$J?:)\CG>_.#[@8'X5X5\8] _L7Q[<3QIMM]14728Z;CPX^NX$_P#
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45782735377408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001631574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 30,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WAVE LIFE SCIENCES LTD.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">U0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1356880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7 Straits View #12-00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Marina One<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">East Tower<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">SG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">018936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6236 3388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">$0 Par Value Ordinary Shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WVE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( *Z)7EEED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "NB5Y9)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "NB5Y999!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d862759d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d862759d8k.htm">d862759d8k.htm</File>
    <File>wve-20241030.xsd</File>
    <File>wve-20241030_lab.xml</File>
    <File>wve-20241030_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d862759d8k.htm": {
   "nsprefix": "wve",
   "nsuri": "http://www.wavelifesciences.com/20241030",
   "dts": {
    "inline": {
     "local": [
      "d862759d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "wve-20241030.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "wve-20241030_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wve-20241030_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-10-30_to_2024-10-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d862759d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-10-30_to_2024-10-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d862759d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.wavelifesciences.com//20241030/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-247660-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-247660-xbrl.zip
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MY,+1G=76XJ[TW)#KH"%5$D?-8JOE(&XAR-MI6<JLC)Y^NEIIC=?9AL^"*\
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M..O#"A7?N+S7-R[%"E]GX^VO@RRK^.*Z&EE\N5SD",W[6?5\^!IN_8;NQO\
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M5&0",YZ#!6$LHSF6[\%+, .LQ2'RD0P-H3Y@&=X!K^"_P T2M1 RZ $E,.O
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M%")0H99B^^>SG=(,M%RC!DGZ-P#B3,&?3V0PXN)P82N@/YC"U?'&!E[R467
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M+F]Q)FWQ%=_ZG8(2Z),L4K_4POFU=T&."9IUY&F$:44OJ6TC'1"H8W@6Y\/
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M;"=TTJ?K07-HTJRH21Q%D;W2@J\YP=<07H8;G$#K[K9_*8PY'1IW'I?6=:/
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M5$SAE.?CU=KZPJKVZYC]#T<A%]%>36ZQP?[>M;AB_]E?;V++WU!+ 0(4 Q0
M   ( *Z)7EEZE9*KI@\   A?   .              "  0    !D.#8R-S4Y
M9#AK+FAT;5!+ 0(4 Q0    ( *Z)7ED9"!L(^!8  )Y;   1
M  "  =(/  !D.#8R-S4Y9&5X.3DQ+FAT;5!+ 0(4 Q0    ( *Z)7EFXB$#H
M0@,  &(+   0              "  ?DF  !W=F4M,C R-#$P,S N>'-D4$L!
M A0#%     @ KHE>64W7WQ5G!@  =D8  !0              ( !:2H  '=V
M92TR,#(T,3 S,%]L86(N>&UL4$L! A0#%     @ KHE>6<16+CB[!   -RP
M !0              ( ! C$  '=V92TR,#(T,3 S,%]P<F4N>&UL4$L%!@
0   %  4 /0$  .\U      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d862759d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wve-20241030.xsd" xlink:type="simple"/>
    <context id="duration_2024-10-30_to_2024-10-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001631574</identifier>
        </entity>
        <period>
            <startDate>2024-10-30</startDate>
            <endDate>2024-10-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-237">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-10-30_to_2024-10-30"
      id="Hidden_dei_EntityCentralIndexKey">0001631574</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-248">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-249">2024-10-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-250">WAVE LIFE SCIENCES LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-251">U0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-252">001-37627</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-253">98-1356880</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-254">7 Straits View #12-00</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-255">Marina One</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-256">East Tower</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-257">SG</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-258">018936</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-259">65</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-260">6236 3388</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-261">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-262">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-263">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-264">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-265">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-266">$0 Par Value Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-267">WVE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-10-30_to_2024-10-30" id="ixv-268">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
